🔗 Share this article

This year's prestigious award in medical science was granted for transformative discoveries that illuminate how the immune system attacks dangerous infections while protecting the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their work uncovered specialized "security guards" within the immune system that remove malfunctioning immune cells that could harming the body.

The discoveries are now paving the way for innovative therapies for immune disorders and malignancies.

These winners will divide a monetary award worth 11m SEK.

Decisive Discoveries

"The research has been essential for understanding how the immune system functions and the reason we don't all develop severe autoimmune diseases," commented the head of the award panel.

The team's research address a core mystery: In what way does the defense system protect us from numerous infections while leaving our own tissues unharmed?

Our body's protection system employs immune cells that search for signs of infection, even viruses and germs it has not met before.

These cells employ detectors—known as receptors—that are generated randomly in countless variations.

This provides the defense network the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably creates white blood cells that can target the body.

Protectors of the Body

Researchers earlier knew that a portion of these problematic white blood cells were eliminated in the thymus—the site where immune cells develop.

The latest award recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to disarm any defenders that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The prize committee stated, "The discoveries have established a novel area of research and spurred the creation of new therapies, for instance for cancer and immune disorders."

Regarding malignancies, T-regs prevent the body from attacking the growth, so research are aimed at reducing their numbers.

In autoimmune diseases, experiments are testing boosting regulatory T-cells so the body is no longer being harmed. A similar approach could also be useful in minimizing the risks of organ transplant failure.

Innovative Experiments

Prof Sakaguchi, from a Japanese institution, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

The researcher showed that injecting defense cells from other animals could stop the illness—implying there was a system for preventing immune cells from attacking the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in mice and humans that led to the discovery of a genetic factor critical for how T-regs operate.

"Their pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly targeting the healthy cells," said a prominent biological science specialist.

"The work is a remarkable illustration of how fundamental biological study can have far-reaching implications for human health."